Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
Year: 2020
Type: article
Study design: Observational Study
Authors: Alexander Coltoff, Ruben Mesa, Jason Gotlib, Jessica Shulman, Raajit K. Rampal, Olivia Siwoski, Abdulraheem Yacoub, Alison Moliterno, Anna Yang, Evan Braunstein, Aaron T. Gerds, Gabriela S. Hobbs, Elliott F. Winton, Swati Goel, Martha Wadleigh, Douglas Tremblay, Erin Moshier, John Mascarenhas
Institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, Stanford Medicine, Stanford Cancer Institute, Stanford University, Memorial Sloan Kettering Cancer Center, University of Kansas, The University of Kansas Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, Cleveland Clinic, Harvard University, Massachusetts General Hospital, Emory University, Winship Cancer Institute, Albert Einstein College of Medicine, Montefiore Medical Center, Dana-Farber Cancer Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3031174418
